If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.
If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.
In National Geographic’s “Expedition: Saving Our Seas,” it’s all hands on deck 
The ‘hell chicken’ dinosaur was a real terror — to fruit 
The brain’s fear center moonlights as the save button for memories 
Europe’s Hera mission is ready to double down on asteroid science 
Stone Age children left fingerprints on ancient art projects 
This magic mushroom can kill 
When the rains fail: Preparing for drought in Central America 
‘Here, you can eat until you’re full’: Oleshky evacuees savour first proper meals in years 
COP31: National Oil Companies Must Lead Global Shift Away from Fossil Fuels, Says NRGI Expert 
COP31: Climate finance falls short as calls grow for polluters to pay